Can we still improve long term oncologic outcome of patients with anal carcinoma after multimodality treatment?

Date 28 June 2017
Event ESMO World Congress on Gastrointestinal Cancer 2017
Session ESMO World Congress on Gastrointestinal Cancer 2017
Topics Gastrointestinal Cancers
Anal Cancer
Presenter Laurentia Gales
Citation Annals of Oncology (2017) 28 (suppl_3): iii13-iii136. 10.1093/annonc/mdx261
Authors L. Gales, L. Serbanescu, M. Georgescu, V. Moldoveanu, F. Curea, I. Botnariuc, O. Trifanescu
  • /

Abstract

Anal cancers (AC) are relatively rare tumors but their incidence is increasing in the last decades and there are a lot of controversies regarding optimal sequencing and treatment modality for these patients. The aim of this study was to evaluate the multimodality treatment in patients with locally advanced anal carcinoma.